DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11
Science Signaling · 2023
DOI: 10.1126/scisignal.adg5171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2023. Verfasst von Jia Tong Loh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Republic o…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Singapore Ministry of Health’s National Medical Research Council under its Open-Fund-Individual Research, Open Fund-Young Individual Research, A*STAR Career Development Award.
Abstract (Originalsprache)
The scaffolding protein CARD11 is a critical mediator of antigen receptor signaling in lymphocytes. Hypomorphic (partial loss-of-function) mutations in CARD11 are associated with the development of severe atopic dermatitis, in which T cell receptor signaling is reduced and helper T cell differentiation is skewed to an allergy-associated type 2 phenotype. Here, we found that the docking protein DOK3 plays a key role in the pathogenesis of atopic dermatitis by suppressing CARD11 activity. DOK3 interacted with CARD11 and decreased its phosphorylation in T cells by recruiting the catalytic subunit of protein phosphatase 4, thereby dampening downstream signaling. Knocking out Dok3 enhanced the production of the cytokine IFN-γ by T cells, which conferred protection against experimental atopic dermatitis–like skin inflammation in mice. The expression of DOK3 was increased in T cells isolated from patients with atopic dermatitis and inversely correlated with IFNG expression. A subset of hypomorphic CARD11 variants found in patients with atopic dermatitis bound more strongly than wild-type CARD11 to DOK3. Our findings suggest that the strength of the interaction of DOK3 with CARD11 may predispose individuals to developing atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos, Singapore 138648, Republic of Singapore.
- School of Biological Sciences, College of Science, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Republic of Singapore.
- Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Singapore 138671, Republic of Singapore.
- Department of Biological Sciences, National University of Singapore, 16 Science Drive 4, Singapore 117558, Republic of Singapore.
- Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117545, Republic of Singapore.
ORCID-Profile: Jia Tong Loh, Joey Kay Hui Teo, Srinivasaraghavan Kannan, Chandra S Verma, Anand Kumar Andiappan, Hong-Hwa Lim, Kong-Peng Lam
Förderung
- Singapore Ministry of Health’s National Medical Research Council under its Open-Fund-Individual Research
- Open Fund-Young Individual Research
- A*STAR Career Development Award
Zitieren
APA
Loh, J. T., Teo, J. K. H., Kannan, S., Verma, C. S., Andiappan, A. K., Lim, H. H., & Lam, K. P. (2023). DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11. Science Signaling. https://doi.org/10.1126/scisignal.adg5171
Vancouver
Loh JT, Teo JKH, Kannan S, Verma CS, Andiappan AK, Lim HH, et al. DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11. Science Signaling. 2023. doi:10.1126/scisignal.adg5171
BibTeX
@article{Loh2023,
author = {Loh, Jia Tong and Teo, Joey Kay Hui and Kannan, Srinivasaraghavan and Verma, Chandra S and Andiappan, Anand Kumar and Lim, Hong-Hwa and Lam, Kong-Peng},
title = {DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11},
journal = {Science Signaling},
year = {2023},
doi = {10.1126/scisignal.adg5171}
}
EUVIMED